Azam Usman 4
4 · Cue Biopharma, Inc. · Filed Oct 2, 2025
Insider Transaction Report
Form 4
Azam Usman
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Award
Stock Option (right to buy)
2025-09-29+1,875,000→ 1,875,000 totalExercise: $0.72Exp: 2035-09-28→ Common Stock (1,875,000 underlying)
Footnotes (1)
- [F1]This stock option becomes exercisable in 48 monthly installments beginning on September 29, 2026.